William Congreve
Boston life sciences CFO support before a financing round
Boston life sciences CFO support matters most before a financing round starts, not after term sheets arrive. The common mistake is waiting until investors ask for a cash forecast and a clean close. By then, the company is building answers under pressure, and every gap shows.
Why a financing round exposes gaps that were easy to ignore
Most gaps in a life sciences company's finances were tolerable while the company was small. A reconciliation that slipped for a quarter, a grant receivable nobody tracked closely, or a forecast that only the founder understood did not stop daily work. A financing round changes that. Investors and lenders read the same numbers with a different question: can this company keep its commitments over the next stretch of time?
The answer depends on whether the finance function can produce reliable numbers on request. A diligence request can arrive with a short deadline and a list of thirty items. If the team needs weeks to pull a trial balance and explain the differences, the delay itself becomes a signal, even when the underlying science and the business are sound.
Life sciences companies face extra layers of complexity. Research spending is uneven, milestone payments depend on clinical or regulatory events, and licensing income may arrive in irregular amounts. A founder who has managed these through instinct may find that instinct hard to explain to a new investor who wants a model with stated assumptions and a clear reason behind each one.
Keep the full picture in view. The purpose of support before a round is not to make the company look stronger than it is. It is to make the financial position clear, including the risks, so the board and what's a interim CFO in Massachusetts prospective investors can judge the choices ahead. A useful report should show both where the money stands today and what each option would do to it.
Many companies consider outside finance help only after a deal is already on the table. Starting earlier, even with a narrow scope, gives the team time to fix what diligence is likely to find. Fixing a reconciliation process in calm weeks is far easier than explaining an unresolved difference to a lender who has a deadline of its own.
The same logic applies to other organizations. A nonprofit research group spun out of a university, or a nonprofit with a commercial subsidiary, faces similar questions about forecasts, reporting, and controls. Grant funding should not be assumed to arrive on schedule, and grant conditions can shape the forecast as much as product milestones do. The first step is the same: know what the organization has, what it owes, and what it still needs to learn.
Interim, fractional, and permanent CFO arrangements compared
Three arrangements come up most often when a company needs senior financial leadership. An interim CFO fills the role for a defined period, usually during a leadership gap or a specific project. A fractional CFO works part time, often on a recurring schedule, and may serve more than one company. A permanent CFO is a full-time executive hire with a longer horizon and a broader role in the company's structure.
Each model carries trade-offs. Interim support brings experience quickly, but the engagement usually ends when the search for a permanent hire ends or the project is finished, so the company must plan the handover. A fractional arrangement ties cost more closely to the scope of work, though availability during a busy stretch may be limited. A permanent hire builds continuity and ownership, yet it adds a fixed executive cost before the company has secured new capital.
| Question | Interim CFO | Fractional CFO | Permanent CFO |
|---|---|---|---|
| Typical use | Leadership gap or a defined project | Ongoing part-time strategic finance | Long-term executive role |
| Time commitment | Often close to full-time for the engagement | Agreed hours each week or month | Full-time |
| Continuity after the engagement | Depends on the quality of the handover | Depends on documentation and the internal team | Built into the role |
| Fit before a financing round | Covering a departure during diligence | Building forecasts and reporting with a limited budget | Company with stable finance needs and capacity to hire |
A neutral comparison matters because many sources present one model as the answer for every company. Ask any provider which arrangement they recommend and what they would give up by recommending a different one. A useful advisor can explain the case for each option, including the case against their own.
Before choosing, write down the decisions the company must make in the next six months. A bridge round, a term loan, and a licensing negotiation call for different skills. A CFO who has closed debt facilities may not be the right person to rebuild a month-end close, and a strong operator may not have the experience to walk a buyer through a purchase agreement.
Ask for specifics about who will do the work. Some engagements place a senior lead who reviews the output while more junior staff build the model and prepare the schedules. That structure can be efficient, but the company should know who is responsible for each deliverable, how work is reviewed, and how questions are escalated when the lead is not in the room.
A diagnostic checklist for the first weeks of support
Onboarding should start with a diagnosis, not a template. In the first weeks, a finance leader should be able to answer direct questions about where the company stands. The list below is a starting point for an internal review, whether the work is done by outside help or by your own team.
- Which bank accounts, grant accounts, and payment platforms hold cash, and who can approve payments from each one?
- How long does the month-end close take, and which entries are routinely late or adjusted after the fact?
- Which revenue, grant, or milestone payments are recognized, deferred, or still uncertain?
- What forecast exists today, who built it, and which assumptions have never been tested against actual results?
- Which obligations come due in the next twelve months, including leases, loan payments, and payroll commitments?
- Which records would an investor or auditor request first, and where are they stored?
Each question can be answered without a large project. The goal is to identify the three or four issues most likely to delay a round, then rank them by how much they affect cash and credibility. A missing contract that controls a major revenue line matters more than a small inconsistency in expense coding, even though both need attention.
The first two questions reveal whether the company can produce reliable numbers at all. If approvals are informal and the close regularly runs past its target, investors will notice before they see the forecast. Treat these answers as operating facts rather than as failings, because they point directly to the fixes that come first.
Write the results in plain language. A short memo that names each gap, the owner responsible for fixing it, and the point at which the fix must be finished will help the board see the choices ahead. Avoid long narrative reports that describe effort without stating the status of each item.
The most common surprise is not a missing number but an unclear one. Two people may report different cash positions because they treat restricted grant funds differently, or because one counts payments in transit and the other does not. Settle the definitions first, write them down, and apply them the same way in every report that follows.
Cash forecasting and working capital before investors ask
A cash forecast is the document investors examine most closely in a financing round, because it turns plans into dates and amounts. For a life sciences company, the forecast should separate operating spending from research commitments, equipment purchases, and payments tied to milestones. Mixing these together hides the timing risk that most investors care about.
Build the forecast from the bottom up wherever you can. Payroll, rent, insurance, and vendor terms are usually known with reasonable confidence. Revenue from licensing, grants, or collaborations should be shown with a clear status, such as signed, under negotiation, or expected, rather than as one optimistic line. A hypothetical company that expects a milestone payment but has not yet signed the agreement should show the forecast both with and without that payment.
Working capital needs the same care. Slow customer payments, inventory bought ahead of a launch, and prepaid research contracts can drain cash even when the income statement looks healthy. Track receivables by counterparty and payables by due date, then compare the results with the bank balance every week. The gap between those two views often shows where the forecast needs work.
Test the forecast before presenting it. Ask someone outside the finance work to change one assumption, such as a six-month delay in a regulatory submission, and see whether the company runs short of cash under that case. If the model cannot answer that question quickly, it is not ready for a room with investors, and the team should simplify it until the logic is visible.
Forecasting has limits that should be stated openly. A forecast is an estimate, not a promise, and clinical, regulatory, and partnering timelines are often outside the company's control. State the assumptions, the source of each one, and the confidence level of each major line. Then update the model on a fixed schedule so the board sees how the picture has changed.
Investor-ready reporting and revenue recognition questions
Investor reporting should answer three questions: how the company performed, why it performed that way, and what changes the outlook. A clean monthly package with a short narrative, an explanation of variances, and a list of open items usually earns more trust than a long deck full of charts. Accuracy comes first, and format comes second.
Revenue recognition is a common source of confusion for companies with licensing or collaboration agreements. ASC 606 sets out the framework for recognizing revenue from contracts with customers, and the way a company identifies its performance obligations can change when revenue appears in the books. A finance leader should confirm the treatment with the company's accountant or auditor before diligence begins, not during it.
Grant funding adds its own rules. Restricted funds, cost-sharing terms, and reporting deadlines must be tracked separately from unrestricted cash. A reporting package that combines them without clear labels can overstate what the company is free to spend, and an investor who finds that overstatement will reasonably question the rest of the package.
Build a reporting calendar. Decide who prepares each schedule, which reviews happen before release, and how revisions are logged after a report goes out. When an investor asks why a number changed from one month to the next, the answer should be in the file, not in someone's memory of a phone call.
Keep the list of metrics short and matched to the stage of the business. Early companies may track burn, runway, and progress against milestones. Companies with product revenue may add gross margin and receivable aging. Every metric should come with its definition, because the same label can mean different things in different accounting systems and different contracts.
Controls and audit readiness that hold up under diligence
Internal controls are the habits that make numbers trustworthy: approvals, reconciliations, segregation of duties, and documented closing steps. In a small company these habits may be informal and still work well for the people involved. In diligence, informal controls are hard to evidence, and an investor's accountant will ask for proof that a payment was approved by the right person.
Audit preparation starts with the list of likely requests. Auditors and diligence teams usually ask for bank reconciliations, key contracts, board minutes, equity records, and tax filings. A company that keeps these documents in one indexed location saves time and reduces the chance of giving two different answers to the same question.
Accounting systems matter, but they do not fix weak processes. QuickBooks and NetSuite are both used by companies at different stages, and either can support a reasonable close if the chart of accounts and approval steps are clear. Changing systems in the middle of a financing round usually adds risk, so plan any migration for a quieter period and keep the old records accessible.
Outsourced accounting and bookkeeping can fill real gaps, but the company still owns its decisions. Ask the provider who reviews entries, how exceptions are escalated, and exactly what the company receives each month. A monthly package that arrives late is a control problem, even when the bookkeeping itself is accurate, because the people making decisions are working from old information.
Consider a short readiness review before the round opens. Pick the five records a diligence team would ask for first, check whether each one exists and ties to the ledger, and fix any mismatch while there is still time. This review does not need to be a full audit, and its purpose is to find the problems before someone outside the company does.
How transaction support works in fundraising, lending, and sales
Transaction support covers more than the closing call. For a fundraising round, it may include preparing the data room, shaping the financial story, and answering diligence questions as they arrive. For debt financing, the work often focuses on covenants, borrowing base or reporting requirements, and the calendar of lender reports. For a sale or merger, positioning and negotiation work usually begin earlier than most founders expect.
Positioning means explaining the business in terms that a buyer or investor can test. That includes identifying which revenue is recurring, which depends on a single partner or customer, and which assumptions remain open. Clear positioning reduces the number of surprises in later rounds of questions, and it gives the company more control over how the story is told.
Negotiation support is often less visible. A finance leader can model the effect of different valuation or payment structures, check whether a proposed covenant fits the forecast, and flag terms that move risk onto the company. The decisions remain with the board and its legal counsel, but the board should have clear numbers behind each option before it decides.
Closing support involves coordinating schedules, the funds flow, and the post-closing reporting that follows. Missed deliverables late in the process can delay funding, so track each closing condition in a single list with one named owner for every item. Review that list at a fixed time each day during the final stretch.
No support can guarantee that a financing, loan, or sale will close, or the terms on which it would close. Ask any advisor to describe what they will do, what they will not do, and what they expect the company to provide. A written scope prevents later disagreement about who owned each task, and it makes it easier to judge whether the support is working.
A checklist to bring to the board before the round
Bring a short, concrete list to the board rather than a general request for help. Board members can then weigh the options against the cash position and the timeline. The questions below are meant for discussion, and rayandco.uk most of them can be answered in one meeting if the underlying materials are ready before the session begins.
- What is the current cash position, what is the runway under the base and downside forecasts, and which assumptions explain the gap between them?
- Which leadership gap are we covering: a departure, a capacity shortage, or a need for transaction experience?
- Which arrangement fits the decisions due in the next six months, interim, fractional, or permanent, and what would we give up by choosing it?
- What must be true in our records, reporting, and controls before outside investors or lenders begin diligence?
- Who owns each open item, how much time and attention does it require, and what happens if it slips?
- What would make us pause or change course, and who makes that decision?
Use these questions to set scope. A narrow mandate, such as a forecast rebuild combined with a diligence readiness review, is usually easier to evaluate than a broad engagement with unclear deliverables. The narrower scope also makes it simpler to decide whether to continue after the first milestone.
Evaluate success in terms the board can see. Look for a forecast the team updates without outside help, a close that finishes on a predictable schedule, a data room that answers the first wave of requests without rework, and a written record of key decisions. Not every round succeeds, but a company that understands its position makes better choices whatever the outcome.
For a life sciences company in Boston or elsewhere in Massachusetts, a practical recommendation is to schedule a finance review before the round opens, then repeat it at each major milestone. Keep the full picture in view: the financial position, the options on the table, and the cost of each option in time, money, and attention. That is the information a board needs to decide well.
Share Profile